← SynDRA
BRD-K40331046
SynDRA canonical compound SYN0062618 — structure-anchored drug synonym record
Clinical phase
Preclinical
Primary target(s)
CCNA2 | CCNE1 | CCNH | CCNT1 | CDK1 | CDK2 | CDK5 | CDK7 | CDK9
Mechanism of action
CDK inhibitor
All known targets
CCNA2
CCNE1
CCNH
CCNT1
CDK1
CDK2
CDK5
CDK7
CDK9
Mechanisms of action (all sources)
cyclin-dependent kinase inhibitor
Cross-references
PubChem CID:
10224714
ChEMBL:
CHEMBL518800
DrugBank:
DB08463
PDB:
RC8
LINCS BRD: BRD-K40331046
Synonyms
CR8-(R)
RefChem:396983
CR8, (R)-Isomer
(R)-CR8
(R)?-?CR8
MFCD18785641
CR8
3ddp
RC8
CDK inhibitor CR8
CR8; (R)-Isomer
CR8 3HCl (R)
CR-8
orb1309189
SCHEMBL13001902
SCHEMBL29644968
GTPL11065
HMS3229B13
BDBM50154937
EX-A11115
AKOS025394606
CR8, >=95% (HPLC)
EBC-380069
T12617L
NCGC00370890-01
DA-48763
HY-18340
MS-27687
SY278963
C6800
CS-0007451
NS00071534
G60966
EN300-25631346
F862321
BRD-K40331046-305-01-5
(2R)-2-[[9-(1-Methylethyl)-6-[[[4-(2-pyridinyl)phenyl]methyl]amino]-9H-purin-2-yl]amino]-1-butanol
(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol
Look up BRD-K40331046 in the interactive SynDRA portal →